{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:57:35Z","timestamp":1794265055631,"version":"4.9.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["23-05474S"],"award-info":[{"award-number":["23-05474S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016046","name":"Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200125"],"award-info":[{"award-number":["451-03-136\/2025-03\/200125"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-137\/2025-03\/200125"],"award-info":[{"award-number":["451-03-137\/2025-03\/200125"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005289","name":"Autonomous Province of Vojvodina Provincial Secretariat for Higher Education and Scientific Research Activities","doi-asserted-by":"publisher","award":["003056514 2024 09418 003 000 000 001\/1"],"award-info":[{"award-number":["003056514 2024 09418 003 000 000 001\/1"]}],"id":[{"id":"10.13039\/501100005289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117850","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:38:45Z","timestamp":1749159525000},"page":"117850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Heterocyclic androstane derivatives targeting hormone-related cancers: Synthesis, bioactivity and docking studies"],"prefix":"10.1016","volume":"296","author":[{"given":"Tijana Lj.","family":"\u0160esti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofija S.","family":"Beki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja A.","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kvasnicov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"\u0160tenclov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"R\u00e1rov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andjelka S.","family":"\u0106eli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-3640","authenticated-orcid":false,"given":"Jovana J.","family":"Ajdukovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina P.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117850_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2017.06.006","article-title":"Auspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs","volume":"73","author":"Tantawy","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib2","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117850_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1359-6446(04)03115-0","article-title":"Compound lipophilicity for substrate binding to human P450s in drug metabolism","volume":"9","author":"Lewis","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117850_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112016","article-title":"Thiazole-containing compounds as therapeutic targets for cancer therapy","volume":"188","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137510","article-title":"Thiazole moiety: a promising scaffold for anticancer drug discovery","volume":"1303","author":"Kassem","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117850_bib6","doi-asserted-by":"crossref","first-page":"17552","DOI":"10.1021\/acsomega.2c07569","article-title":"Design and synthesis of thiazole scaffold-based small molecules as anticancer agents targeting the human lactate dehydrogenase A enzyme","volume":"8","author":"Sharma","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117850_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137365","article-title":"New naphthoquinone thiazole hybrids as carbonic anhydrase and cholinesterase inhibitors: synthesis, crystal structure, molecular docking, and acid dissociation constant","volume":"1301","author":"Efeoglu","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117850_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100294","article-title":"Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds","volume":"354","author":"Sever","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117850_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2478\/v10007-007-0003-y","article-title":"Synthesis and evaluation of anti-inflammatory, analgesic ulcerogenic and lipid peroxidation properties of ibuprofen derivatives","volume":"57","author":"Amir","year":"2007","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2025.117850_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejmech.2014.12.035","article-title":"1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold","volume":"92","author":"Haider","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s43440-020-00154-7","article-title":"Thiadiazole derivatives as anticancer agents","volume":"72","author":"Szeliga","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2025.117850_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105009","article-title":"Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors","volume":"113","author":"Askin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2331085","article-title":"New N-(1,3,4-thiadiazole-2-yl)acetamide derivatives as human carbonic anhydrase I and II and acetylcholinesterase inhibitors","author":"Dawbaa","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.117850_bib14","article-title":"Recent progress on anti-cancer activity of thiadiazoles: a review, results","volume":"13","author":"Santhosh","year":"2025","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.117850_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200618","article-title":"Thiazolidinone\u2010heterocycle frameworks: a concise review of their pharmacological significance","volume":"18","author":"Seboletswe","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117850_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1515\/chem-2021-0032","article-title":"A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity","volume":"19","author":"Sever","year":"2021","journal-title":"Open Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113135","article-title":"4-Thiazolidinone-Bearing hybrid molecules in anticancer drug design","volume":"23","author":"Roszczenko","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117850_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1755","article-title":"Targeting steroid hormone receptors for anti\u2010cancer therapy\u2012a review on small molecules and nanotherapeutic approaches","volume":"14","author":"Mahadik","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2025.117850_bib19","series-title":"Glucocorticoid Signaling, Springer, New York","first-page":"315","article-title":"Glucocorticoids and cancer","author":"Pufall","year":"2015"},{"key":"10.1016\/j.ejmech.2025.117850_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/1871520617666171114111721","article-title":"Steroidal anticancer agents: an overview of estradiol-related compounds","volume":"18","author":"Minorics","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114366","article-title":"New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold","volume":"237","author":"Pippione","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1039\/D2MD00387B","article-title":"X-ray structure of human aldo\u2013keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis","volume":"14","author":"Marinovi\u0107","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106362","article-title":"Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: synthesis, characterization, in vitro and in silico studies","volume":"233","author":"\u0160esti\u0107","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108596","article-title":"New A-homo lactam D-homo lactone androstane derivative: synthesis and evaluation of cytotoxic and anti-inflammatory activities in vitro","volume":"157","author":"Savi\u0107","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2025.117850_bib25","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bmc.2015.02.001","article-title":"Synthesis, structural analysis and antitumor activity of novel 17\u03b1-picolyl and 17(E)-picolinylidene A-modified androstane derivatives","volume":"23","author":"Ajdukovi\u0107","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib26","doi-asserted-by":"crossref","first-page":"37449","DOI":"10.1039\/D1RA07613B","volume":"11","author":"Ajdukovi\u0107","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117850_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106545","article-title":"Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties","volume":"242","author":"Jankovi\u0107","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib28","first-page":"675","article-title":"Chemical transformations of 3\u03b2,17\u03b2-dihydroxy-16-oximino-5-androstene","volume":"31","author":"Penov-Ga\u0161i","year":"2000","journal-title":"Acta Period. Technol."},{"key":"10.1016\/j.ejmech.2025.117850_bib29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s11224-012-9986-1","article-title":"Synthesis, X-ray structural analysis, and cytotoxic activity of some new androstane D-homo lactone derivatives","volume":"23","author":"\u0110urendi\u0107","year":"2012","journal-title":"Struct. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2006.10.002","article-title":"Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives","volume":"72","author":"Penov Ga\u0161i","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2025.117850_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.crci.2018.07.011","article-title":"Novel 4-azaandrostenes as prostate cancer cell growth inhibitors: synthesis, antiproliferative effects, and molecular docking studies","volume":"22","author":"Brito","year":"2019","journal-title":"CR Chim."},{"key":"10.1016\/j.ejmech.2025.117850_bib32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cjoc.201200126","article-title":"Novel steroidal (6R)-Spiro-1,3,4-thiadiazoline derivatives as anti-bacterial agents","volume":"30","author":"Khan","year":"2012","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2017.07.031","article-title":"Anticancer potential of new steroidal thiazolidin-4-one derivatives. Mechanisms of cytotoxic action and effects on angiogenesis in vitro","volume":"174","author":"\u017divkovi\u0107","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.steroids.2019.02.015","article-title":"Shamsuzzaman, steroidal thiazolidinone derivatives: design, synthesis and their molecular interaction with human serum albumin","volume":"148","author":"Ansari","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2025.117850_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117850_bib36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/pharmrev.120.000122","article-title":"Aldo-keto reductases and cancer drug resistance","volume":"73","author":"Penning","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117850_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2025.117850_bib38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1039\/C8MD00077H","article-title":"Evaluation of A-ring fused pyridine D-modified androstane derivatives for antiproliferative and aldo\u2013keto reductase 1C3 inhibitory activity","volume":"9","author":"Savi\u0107","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2025.117850_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2007.09.008","volume":"75","author":"Byrns","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117850_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.steroids.2017.12.002","article-title":"Identification of D-seco modified steroid derivatives with affinity for estrogen receptor \u03b1 and \u03b2 isoforms using a non-transcriptional fluorescent cell assay in yeast","volume":"130","author":"Beki\u0107","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2025.117850_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1039\/D0MD00311E","article-title":"Microwave-assisted green synthesis of bile acid derivatives and evaluation of glucocorticoid receptor binding","volume":"12","author":"Vasiljevi\u0107","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0472-8","article-title":"Estrogen alpha receptor antagonists for the treatment of breast cancer: a review","volume":"12","author":"Sharma","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2025.117850_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106269","article-title":"Synthesis of hydrocortisone esters targeting androgen and glucocorticoid receptors in prostate cancer in vitro","volume":"229","author":"Pe\u0159ina","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029716","article-title":"Is the glucocorticoid receptor a key player in prostate cancer?: a literature review","volume":"101","author":"Sakellakis","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.ejmech.2025.117850_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104446","article-title":"Aldo-keto reductase 1C3\u2014Assessment as a new target for the treatment of endometriosis","volume":"152","author":"Ri\u017ener","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117850_bib46","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.95.11.5998","article-title":"Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains","volume":"95","author":"Tanenbaum","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117850_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117850_bib48","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1074\/jbc.M606784200","article-title":"Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17\u03b2-hydroxysteroid dehydrogenase","volume":"282","author":"Qiu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1110\/ps.051353205","article-title":"Comparison of crystal structures of human type 3 3\u03b1\u2010hydroxysteroid dehydrogenase reveals an \u201cinduced\u2010fit\u201d mechanism and a conserved basic motif involved in the binding of androgen","volume":"14","author":"Couture","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2025.117850_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1\u2013AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117850_bib51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jsbmb.2016.03.017","article-title":"Structure activity relationship studies on cytotoxicity and the effects on steroid receptors of AB-functionalized cholestanes","volume":"159","author":"R\u00e1rov\u00e1","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib52","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1039\/D4OB00863D","article-title":"Atropisomeric 1-phenylbenzimidazoles affecting microtubule organization: influence of axial chirality","volume":"22","author":"Posp\u00ed\u0161ilov\u00e1","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cbic.200300606","article-title":"Fluorescent cellular sensors of steroid receptor ligands","volume":"4","author":"Muddana","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.117850_bib54","series-title":"Congreso De Fisicoqu\u00edmica Te\u00f3rica Y Computacional","article-title":"VEGA ZZ: a versatile toolkit for drug design and protein modelling","author":"Pedretti","year":"2008"},{"key":"10.1016\/j.ejmech.2025.117850_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117850_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.117850_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117850_bib58","series-title":"The Pymol Molecular Graphics System, Version 3.0 Schr\u00f6dinger, LLC","author":"DeLano","year":"2002"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:13:41Z","timestamp":1762265621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S0223523425006154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117850","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterocyclic androstane derivatives targeting hormone-related cancers: Synthesis, bioactivity and docking studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117850"}}